Home › GLP-1 Medications › NovoCare
Latest three-month snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each model brings the brand up in recommendation answers.
| model | share of voice | answers |
|---|---|---|
| ChatGPT | 0% | 0 of 24 |
| Claude | 17% | 4 of 24 |
| Gemini | 0% | 0 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 6% | 4 of 72 |
Recurring descriptions in the models' own words, grouped by theme.
“If you use their direct-to-consumer pharmacy, **NovoCare**, the prices are significantly lower than Wegovy's standard ~$1,350 retail list price”
“- Through cash-pay programs available in 2026, Wegovy pills through NovoCare or TrumpRx can reach $149/month for starting doses”
“The general strategy recommended by multiple sources: check manufacturer direct programs first (LillyDirect, NovoCare), then check insurance coverage and savings cards, then compare retail pharmacies including Costco only if the manufacturer options don't work for you.”
“- Oral Wegovy via Walgreens NovoCare is $149/mo for eligible self-pay patients — the lowest 2026 pricing on any FDA-approved GLP-1 at weight-loss doses.”
“- **Have commercial insurance?** Stack the manufacturer savings card — for insured patients, the manufacturer savings card almost always beats GoodRx.”
“If you're paying cash, LillyDirect ($299+) and NovoCare ($199-$349) currently offer the best direct pricing, and the new Wegovy pill at $149/month through pharmacies like Publix is one of the cheapest options overall.”
“If you prefer brand-name medications but your insurance does not cover them, both Eli Lilly (maker of Mounjaro/Zepbound) and Novo Nordisk (maker of Ozempic/Wegovy) offer direct-to-consumer cash programs that bypass traditional high retail costs:”
“If you use their direct-to-consumer pharmacy, **NovoCare**, the prices are significantly lower than Wegovy’s standard ~$1,350 retail list price:”
“This is where the market has shifted a lot recently — manufacturer direct-to-consumer programs are now often *cheaper* than going through insurance with no coverage:”
“Manufacturers now offer direct cash-pay options that dramatically cut costs:”
13 exact quoted mentions in this snapshot, grouped by coded tone. Recent quotes are deduplicated and mixed across models.
“**Wegovy (semaglutide)** via NovoCare: NovoCare Pharmacy repriced Wegovy from $499 to $299/month for the standard pen and launched a $149/month oral pill.”
“Wegovy pills through NovoCare or TrumpRx can reach $149/month for starting doses”
“If you use their direct-to-consumer pharmacy, **NovoCare**, the prices are significantly lower than Wegovy's standard ~$1,350 retail list price”
“the manufacturer (Novo Nordisk) has direct-to-consumer pharmacy channels (like NovoCare) that offer significantly reduced self-pay options”
“for cash-pay patients, LillyDirect and NovoCare beat GoodRx on tirzepatide and semaglutide respectively.”
“Novo Nordisk's cash program (NovoCare) and select discount pharmacy programs offer Wegovy starting at $199 per month”
“The Wegovy standard pen at NovoCare is $299/month”
Which competitors models suggest when shoppers ask for something cheaper.
1 of 13 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| noom.com | 1 |
| pandameds.com | 1 |
| wegovy.com | 1 |
Stores and sites models name as places to buy this brand.
| retailer | mentions |
|---|---|
| NovoCare (direct) | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.